| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
1.25 -0.02 (-0.02%) |
08-15 16:00 |
|
Open: |
1.26 |
Pre close: |
1.27 |
Target:
|
1.49 
|
|
High: |
1.26 |
Low: |
1.24 |
Resistance:
|
1.28
1.32
|
|
Volume: |
117,913 |
Market Cap: |
139M |
Support:
|
1.21
1.01
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.25
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.26 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.30 |
Stochastic Oscillator |
%K(14,3):
|
50.00 |
|
MA(250): |
1.40 |
%D(3): |
43.60 |
|
Average Volume(K) |
3-Month: |
48405
|
52-Week |
High:
|
2.12 |
|
10-Days: |
16738 |
Low: |
1.10 |
|
RSI |
RSI(14):
|
47.83 |
Change(%): |
5.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.320 |
Return on Equity (ttm) |
-70.2 |
Shares Out. (M) |
110.87 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-55.9 |
Shares Float (M) |
97.01 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.50 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.30 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2393 |
|
Book Value (p.s.) |
4.190 |
EBITDA (p.s.) |
-0.189 |
P/E |
-3.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-21.98 |
P/S |
0.00 |
|
Operating Margin |
-63082.00 |
Levered Free Cash Flow
(M) |
-10.47 |
P/CF |
-6.31 |
|
|
|
|
|
|
